Barry D. Quart, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 15,960 shares at $45.00 ($722K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $722k KNSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 830 | $37K | 5.2% |
| 2 | $45.27 | 12,528 | $567K | 78.6% |
| 3 | $45.02 | 2,602 | $117K | 16.2% |
| Total | $45.22 avg | 15,960 | $722K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |
| KNSA | SELL | 2025-06-11 | $1.5M | — | Filing → |